Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
5 studies found for:    20124511 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis
Conditions: Acute Myelogenous Leukemia;   Acute Lymphoid Leukemia;   Myeloproliferative Disease;   Myelodysplastic Syndrome;   Chronic Myeloid Leukemia;   Chronic Myelomonocytic Leukemia
Interventions: Drug: ARM A Cyclophosphamide;   Drug: ARM B Calcineurin inhibitor and methotrexate
2 Unknown  Study of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic Anaemia
Conditions: Haematological Malignancies;   Acquired Aplastic Anaemia
3 Active, not recruiting Combination Chemotherapy, Tacrolimus, and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant For Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: mycophenolate mofetil;   Drug: tacrolimus;   Procedure: allogeneic bone marrow transplantation;   Procedure: bone marrow ablation with stem cell support
4 Recruiting Safety and Efficacy Trial for Alpha-Beta Depleted T-Cell Infusions Post Haplo Transplant
Conditions: Hematologic Neoplasms;   Graft-Versus-Host Disease
Intervention: Device: Alpha-beta depleted T-cell infusion after post-transplant cyclophosphamide.
5 Completed
Has Results
Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant
Condition: Hematologic Neoplasms
Intervention: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

Study has passed its completion date and status has not been verified in more than two years.